Avantor (AVTR) Scheduled to Post Earnings on Thursday

Thursday, July 22, 2021 | MarketBeat

Avantor (NYSE:AVTR) will be posting its quarterly earnings results after the market closes on Thursday, July 29th. Analysts expect Avantor to post earnings of $0.30 per share for the quarter. Individual that are interested in registering for the company's earnings conference call can do so using this link.

Avantor (NYSE:AVTR) last announced its quarterly earnings results on Tuesday, April 27th. The company reported $0.35 EPS for the quarter, topping analysts' consensus estimates of $0.28 by $0.07. The firm had revenue of $1.79 billion during the quarter, compared to analysts' expectations of $1.70 billion. Avantor had a net margin of 3.51% and a return on equity of 41.17%. The company's revenue for the quarter was up 17.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.17 earnings per share. On average, analysts expect Avantor to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Shares of AVTR opened at $36.84 on Thursday. The company has a market capitalization of $21.45 billion, a PE ratio of 127.03, a price-to-earnings-growth ratio of 1.53 and a beta of 1.79. The company has a current ratio of 1.80, a quick ratio of 1.17 and a debt-to-equity ratio of 2.56. Avantor has a 12 month low of $18.27 and a 12 month high of $37.35. The business's 50-day simple moving average is $33.81.

In other Avantor news, EVP Christophe Couturier sold 28,096 shares of Avantor stock in a transaction on Monday, June 28th. The shares were sold at an average price of $35.73, for a total transaction of $1,003,870.08. Following the completion of the sale, the executive vice president now owns 110,077 shares of the company's stock, valued at approximately $3,933,051.21. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP James Bramwell sold 6,112 shares of Avantor stock in a transaction on Tuesday, July 20th. The stock was sold at an average price of $37.00, for a total transaction of $226,144.00. The disclosure for this sale can be found here. Insiders have sold a total of 3,513,268 shares of company stock valued at $109,241,820 in the last ninety days. Company insiders own 2.00% of the company's stock.

A number of research analysts have commented on the stock. TheStreet upgraded shares of Avantor from a "c" rating to a "b-" rating in a research note on Wednesday, May 19th. Morgan Stanley lifted their target price on shares of Avantor from $35.00 to $38.00 and gave the company an "overweight" rating in a research note on Thursday, April 29th. Credit Suisse Group lifted their target price on shares of Avantor from $37.00 to $39.00 and gave the company an "outperform" rating in a research note on Thursday, April 29th. Robert W. Baird lifted their target price on shares of Avantor from $32.00 to $36.00 and gave the company an "outperform" rating in a research note on Thursday, April 29th. Finally, Zacks Investment Research upgraded shares of Avantor from a "hold" rating to a "buy" rating and set a $37.00 target price for the company in a research note on Friday, April 16th. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. The company currently has an average rating of "Buy" and a consensus price target of $35.29.

About Avantor

Avantor, Inc is a provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. It sells materials & consumables, equipment & instrumentation and services & specialty procurement. It operates through the following segments: the Americas, Europe, and AMEA.

Further Reading: How is diluted EPS different from basic EPS?

Earnings History for Avantor (NYSE:AVTR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $1,000 in Avantor right now?

Before you consider Avantor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.

While Avantor currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.